DE69125024D1 - Lhrh-antagonisten - Google Patents

Lhrh-antagonisten

Info

Publication number
DE69125024D1
DE69125024D1 DE69125024T DE69125024T DE69125024D1 DE 69125024 D1 DE69125024 D1 DE 69125024D1 DE 69125024 T DE69125024 T DE 69125024T DE 69125024 T DE69125024 T DE 69125024T DE 69125024 D1 DE69125024 D1 DE 69125024D1
Authority
DE
Germany
Prior art keywords
parent compound
dala
nac
leu
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69125024T
Other languages
English (en)
Other versions
DE69125024T2 (de
Inventor
Shaobo Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Municipal Research Institute For Family Pl
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of DE69125024D1 publication Critical patent/DE69125024D1/de
Publication of DE69125024T2 publication Critical patent/DE69125024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69125024T 1990-11-10 1991-11-08 Lhrh-antagonisten Expired - Lifetime DE69125024T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90108955A CN1036343C (zh) 1990-11-10 1990-11-10 新促黄体生成素释放激素拮抗类似物的制备方法
PCT/EP1991/002110 WO1992008733A1 (en) 1990-11-10 1991-11-08 Lhrh-antagonists

Publications (2)

Publication Number Publication Date
DE69125024D1 true DE69125024D1 (de) 1997-04-10
DE69125024T2 DE69125024T2 (de) 1997-07-17

Family

ID=4881223

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125024T Expired - Lifetime DE69125024T2 (de) 1990-11-10 1991-11-08 Lhrh-antagonisten

Country Status (29)

Country Link
EP (1) EP0564466B1 (de)
KR (1) KR100244624B1 (de)
CN (1) CN1036343C (de)
AT (1) ATE149520T1 (de)
AU (1) AU662496B2 (de)
CA (1) CA2095932C (de)
CZ (1) CZ284168B6 (de)
DE (1) DE69125024T2 (de)
DK (1) DK0564466T3 (de)
EE (1) EE03141B1 (de)
ES (1) ES2100965T3 (de)
FI (1) FI933156A0 (de)
GR (1) GR3023389T3 (de)
HR (1) HRP920585B1 (de)
IE (1) IE913915A1 (de)
LT (1) LT3971B (de)
LV (1) LV10106B (de)
NO (1) NO931697L (de)
NZ (1) NZ240505A (de)
PH (1) PH31178A (de)
PL (1) PL170564B1 (de)
PT (1) PT99458B (de)
RU (1) RU2123499C1 (de)
SI (1) SI9111779B (de)
SK (1) SK281319B6 (de)
UA (1) UA41300C2 (de)
WO (1) WO1992008733A1 (de)
YU (1) YU48831B (de)
ZA (1) ZA918847B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164096T3 (es) * 1992-12-18 2002-02-16 Abbott Lab Antagonistas de lhrh que comprenden restos de aminoacilo modificados en posicion 5 y 6.
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity

Also Published As

Publication number Publication date
DE69125024T2 (de) 1997-07-17
GR3023389T3 (en) 1997-08-29
FI933156A (fi) 1993-07-09
CA2095932A1 (en) 1992-05-11
LT3971B (en) 1996-05-27
CZ84893A3 (en) 1994-02-16
CN1061605A (zh) 1992-06-03
KR100244624B1 (ko) 2000-02-15
UA41300C2 (uk) 2001-09-17
CA2095932C (en) 2003-02-25
LV10106A (lv) 1994-05-10
HRP920585A2 (en) 1997-04-30
PL170564B1 (pl) 1996-12-31
KR930703353A (ko) 1993-11-29
IE913915A1 (en) 1992-05-20
LV10106B (en) 1995-04-20
HRP920585B1 (en) 2000-08-31
YU177991A (sh) 1994-06-24
PT99458B (pt) 1999-02-26
SI9111779A (en) 1997-04-30
CN1036343C (zh) 1997-11-05
FI933156A0 (fi) 1993-07-09
RU2123499C1 (ru) 1998-12-20
EP0564466B1 (de) 1997-03-05
NZ240505A (en) 1993-04-28
AU8861291A (en) 1992-06-11
SI9111779B (en) 2001-12-31
EE03141B1 (et) 1998-12-15
ATE149520T1 (de) 1997-03-15
AU662496B2 (en) 1995-09-07
PL295427A1 (en) 1993-09-06
PT99458A (pt) 1992-10-30
SK45393A3 (en) 1993-10-06
NO931697D0 (no) 1993-05-10
NO931697L (no) 1993-07-07
CZ284168B6 (cs) 1998-09-16
DK0564466T3 (da) 1997-08-25
LTIP1513A (en) 1995-06-26
WO1992008733A1 (en) 1992-05-29
EP0564466A1 (de) 1993-10-13
YU48831B (sh) 2002-03-18
ZA918847B (en) 1992-08-26
ES2100965T3 (es) 1997-07-01
PH31178A (en) 1998-03-20
SK281319B6 (sk) 2001-02-12

Similar Documents

Publication Publication Date Title
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
EA199800559A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
EA199800564A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
DK0564466T3 (da) LHRH-antagonister
DE69331721T2 (de) Neue carbamazepin hapten Analoge
CO5011087A1 (es) Antagonistas de receptores de vitronectina
RU93004994A (ru) Продукты, применение и способ получения антагонистов гормона, стимулирующего выделение лютеинизирующего гормона
ES2080621T3 (es) Preparacion de uso cutaneo.
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
ES2089548T3 (es) Benzhidrilaminas sustituidas como agentes de conexion para sintesis de peptidos en fase solida.
SE8704240D0 (sv) Analgesic preparations
IT1204664B (it) Macchina spruzzatrice principalmente per la dispersione di soluzione di spruzzatura proporzionatamente all'area
TR200002293T2 (tr) Farmasötik bileşimler.
TR199900013T2 (xx) Yeni bile�ikler.
ES2191753T3 (es) Antagonistas de lhrh.
BE1003340A3 (fr) Nouvelle utilisation therapeutique des alpha-aminofluorocetones.
ES2068980T3 (es) Procedimiento para la preparacion de diterciobutoxidiacetoxisilano.
ATE37376T1 (de) Nonapeptid- und decapeptidanaloge von lhrh mit wirkung als lhrh antagonisten, ihre herstellung und diese enthaltende zusammensetzungen.
RU92009228A (ru) Пептидный антагонист тиролиберина
DE59009367D1 (de) Vasopressin-Analoga,ihre Herstellung und ihre pharmazeutische Verwendung.
TH9794EX (th) อนุพันธ์ต่าง ๆ ของ 4-ซับสทิทิวเทด พิราโซโล[3,4,-d] พิริมิดีน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TIANJIN MUNICIPAL RESEARCH INSTITUTE FOR FAMILY PL